» Articles » PMID: 28470689

Human Papillomavirus E7 Protein Detection As a Method of Triage to Colposcopy of HPV Positive Women, in Comparison to Genotyping and Cytology. Final Results of the PIPAVIR Study

Abstract

The objective of the presented cross-sectional-evaluation-screening study is the clinical evaluation of high-risk(hr)HPVE7-protein detection as a triage method to colposcopy for hrHPV-positive women, using a newly developed sandwich-ELISA-assay. Between 2013-2015, 2424 women, 30-60 years old, were recruited at the Hippokratio Hospital, Thessaloniki/Greece and the Im Mare Klinikum, Kiel/Germany, and provided a cervical sample used for Liquid Based Cytology, HPV DNA genotyping, and E7 detection using five different E7-assays: "recomWell HPV16/18/45KJhigh", "recomWell HPV16/18/45KJlow", "recomWell HPV39/51/56/59", "recomWell HPV16/31/33/35/52/58" and "recomWell HPVHRscreen" (for 16,18,31,33,35,39,45,51,52,56,58,59 E7), corresponding to different combinations of hrHPVE7-proteins. Among 1473 women with eligible samples, those positive for cytology (ASCUS+ 7.2%), and/or hrHPV DNA (19.1%) were referred for colposcopy. Cervical Intraepithelial Neoplasia grade 2 or worse (CIN2+) was detected in 27 women (1.8%). For HPV16/18-positive women with no triage, sensitivity, positive predictive value (PPV) and the number of colposcopies needed to detect one case of CIN2+ were 100.0%, 11.11% and 9.0 respectively. The respective values for E7-testing as a triage method to colposcopy ranged from 75.0-100.0%, 16.86-26.08% and 3.83-5.93. Sensitivity and PPV for cytology as triage for hrHPV(non16/18)-positive women were 45.45% and 27.77%; for E7 test the respective values ranged from 72.72-100.0% and 16.32-25.0%. Triage of HPV 16/18-positive women to colposcopy with the E7 test presents better performance than no triage, decreasing the number of colposcopies needed to detect one CIN2+. In addition, triage of hrHPV(non16/18)-positive women with E7 test presents better sensitivity and slightly worse PPV than cytology, a fact that advocates for a full molecular screening approach.

Citing Articles

Do Human Papilloma Virus and Cytological Testing Results Before Colposcopy Alter the Pathological Grading of Colposcopy Acetic Acid Visual Examination?: A Retrospective Study.

Gao S, Qian B, Wang T, Wang J Int J Womens Health. 2025; 17:201-209.

PMID: 39902401 PMC: 11789670. DOI: 10.2147/IJWH.S490355.


Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis.

Downham L, Jaafar I, Rol M, Nyaga V, Valls J, Baena A Br J Cancer. 2023; 130(4):517-525.

PMID: 37973957 PMC: 10876647. DOI: 10.1038/s41416-023-02490-w.


Molecular triaging options for women testing HPV positive with self-collected samples.

Taghavi K, Zhao F, Downham L, Baena A, Basu P Front Oncol. 2023; 13:1243888.

PMID: 37810963 PMC: 10560038. DOI: 10.3389/fonc.2023.1243888.


HPV16 E7 oncoprotein test as a triage strategy for HPV16-positive women in cervical cancer screening: long-term follow-up outcome.

Wang X, Shuai G, Xu J, Liu M, Zhao J, Zhang N Front Oncol. 2023; 13:1221962.

PMID: 37795449 PMC: 10546426. DOI: 10.3389/fonc.2023.1221962.


Human Papillomavirus E7 and p16 mRNA Multiplexed Quantification by a QuantiGene Proof-of-Concept Assay Sensitively Detects Infection and Cervical Dysplasia Severity.

Skof A, Rotenberg L, Hannemann P, Thies S, Boschetti-Grutzmacher E, Kaufmann A Diagnostics (Basel). 2023; 13(6).

PMID: 36980443 PMC: 10047034. DOI: 10.3390/diagnostics13061135.